Found 16 matching trials
FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) PHASE3 This study is an international, multi-center, randomized, double-blind, pla...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension PHASE3 This study provided/continued to provide oral treprostinil (UT-15C SR; trep...
Show More Location
The Kirklin Clinic
Learn More & Join Trial
Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine PHASE1 This study will compare the bioavailability and pharmacokinetics of the 0.5...
Show More Learn More & Join Trial
Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso® PHASE2 The purpose of this multi-center, open-label, safety and tolerability study...
Show More Location
The University of Alabama at Birmingham
Learn More & Join Trial
A Pharmacokinetic Substudy of the TDE-PH-304 Protocol PHASE3 A sub-study to the TDE-PH-304 protocol to assess the pharmacokinetics of pa...
Show More Location
University of Rochester Medical Center
Learn More & Join Trial
A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension PHASE2 This is a prospective, randomized, parallel group study to assess the hemod...
Show More Location
St. Joseph's Hospital and Medical Center
Learn More & Join Trial
Remodulin® to Oral Treprostinil Transition PHASE2 This multi-center, open-label study will assess the tolerability and safety...
Show More Location
Arizona Pulmonary Specialists
Learn More & Join Trial
Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension PHASE3 This study is an international, multi-center, randomized, double-blind, pla...
Show More Location
University of Alabama-Birmingham
Learn More & Join Trial
Three Times Daily Dosing of UT-15C PHASE1 To evaluate the pharmacokinetics of three-times daily dosing of UT-15C in h...
Show More Learn More & Join Trial
Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities PHASE1 The purpose of this study is to compare the bioavailability of a single 1mg...
Show More Learn More & Join Trial